Suven Pharmaceuticals: June ’22 Results Update
Moneylife Digital Team 07 September 2022
Suven Pharmaceuticals’ (Suven’s) Q1FY22-23 revenue was up by 28% y-o-y (year-on-year) to Rs339 crore, aided by growth in pharma and specialty chemicals CDMO (contract development and manufacturing...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
Get access to complete archives
Rs 5000 + GST
Already a subscriber ? Log in
Free Helpline
Legal Credit